NCT00319319View on ClinicalTrials.gov

Nicotinic Receptor Augmentation of SSRI Antidepressants

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

January 31, 2007

Conditions
Depressive Disorder
Interventions
DRUG

Mecamylamine hydrochloride (Inversine)

Trial Locations (1)

06519

Connecticut Mental Health Center, New Haven

Sponsors
All Listed Sponsors
collaborator

Donaghue Medical Research Foundation

OTHER

lead

Yale University

OTHER